Mukadam

Dr. Lalpathlabs thrust towards 3997

Длинная
Mukadam Обновлено   
NSE:LALPATHLAB   DR LAL PATHLABS LTD
Targets 3478 and 3997 as the 3rd Wave arrives

Good Fundamentals:
High Management Efficiency with a high ROE of 22.80%
Company has a low Debt to Equity ratio (avg) at -0.79 times
With a growth in Net Profit of 161.04%, the company declared Very Positive results in Mar 21
The company has declared positive results for the last 2 consecutive quartersPBT LESS OI(Q) At Rs 97.30 cr has Grown at 191.32 %PAT(Q) At Rs 83.40 cr has Grown at 156.6 %ROCE(HY) Highest at 32.96 %
High Institutional Holdings at 33.53%
These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Сделка закрыта: достигнута тейк-профит цена:
Idea closed at 4000 after achieving 2nd target with profit of 18%
Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.